Skip to content
DraconiticResearch
Search Sources API
220,788 studies31 sourcesUpdated 17 min ago
Peer-reviewedLicence not stated3 Biotech

Machine learning-driven discovery of TGFBR1 inhibitors from Mangifera indica for Atorvastatin-based antidiabetic therapy

  • Raghuvir Keni1
  • Farmiza Begum1
  • Niraja Ranadive1
  • Pawan G. Nayak1
  • Vijayakumar Murugesan2
  • Kommu Pradeep3
  • Mangirish Deshpande4
  • Nandakumar Krishnadas1
  • Panneerselvam Theivendren5
5 affiliations
  1. 1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104 India
  2. 2Department of Pharmaceutics, School of Pharmacy, JSS Academy of Higher Education and Research, Vacoas-Phoenix, Mauritius
  3. 3Faculty of Health Sciences, Villa College, Boduthakurufaanu Magu, Malé, Maldives
  4. 4Department of Pharmacology, PES’s Rajaram and Tarabai Bandekar College of Pharmacy, Ponda, Goa 403401 India
  5. 5Department of Pharmaceutical Chemistry & Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu 600117 India
Read full textDOICite

Related

  1. Association of Non‐Cytochrome P450 3A4‐Metabolized Statins Versus Atorvastatin With Major Adverse Cardiovascular Events in Patients With Cancer Receiving Tyrosine Kinase Inhibitors: A Propensity Score–Matched Target Trial Emulation
    Jing‐Huan Liao, Wei‐Cheng Chang, Hong‐Jie Jhou +3
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDOncologyCrossref
  2. Discovery of Tetra-Substituted Imidazole Inhibitors of Plasmin
    Shakila Silva, Pratibha Periwal, Sonia Rohilla +5
    ChemistrySelectPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Development landscape of ketohexokinase-C (KHK-C) inhibitors for fructose-driven metabolic disorders: from hit discovery to clinical trials.
    Sri Venkata Gopal Ainapurapu, Timir Naskar, Ajwin Joseph Martin +1
    RSC medicinal chemistryPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  4. Discovery of Covalent Wild-Type Isocitrate Dehydrogenase 1 (IDH1) Inhibitors Targeting Cys269
    C. P. Brown, E. O. Harmer, A. Azam +5
    bioRxivPreprintCC BYFull textOncologybioRxiv
  5. Fibrinogen alpha chain is associated with response to immune checkpoint inhibitors in non-small cell lung cancer: a multi-cohort discovery and validation study.
    Hongge Liang, Yan Xu, Minjiang Chen +3
    Journal of translational medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{keni2026machine,
  title = {{Machine learning-driven discovery of TGFBR1 inhibitors from Mangifera indica for Atorvastatin-based antidiabetic therapy}},
  author = {Raghuvir Keni and Farmiza Begum and Niraja Ranadive and Pawan G. Nayak and Vijayakumar Murugesan and Kommu Pradeep and Mangirish Deshpande and Nandakumar Krishnadas and Panneerselvam Theivendren},
  journal = {3 Biotech},
  year = {2026},
  month = oct,
  doi = {10.1007/s13205-026-05088-0},
  url = {https://doi.org/10.1007/s13205-026-05088-0},
}
RIS
TY  - JOUR
TI  - Machine learning-driven discovery of TGFBR1 inhibitors from Mangifera indica for Atorvastatin-based antidiabetic therapy
AU  - Raghuvir Keni
AU  - Farmiza Begum
AU  - Niraja Ranadive
AU  - Pawan G. Nayak
AU  - Vijayakumar Murugesan
AU  - Kommu Pradeep
AU  - Mangirish Deshpande
AU  - Nandakumar Krishnadas
AU  - Panneerselvam Theivendren
PY  - 2026
DA  - 2026/10/12
JO  - 3 Biotech
DO  - 10.1007/s13205-026-05088-0
UR  - https://doi.org/10.1007/s13205-026-05088-0
SN  - 2190-572X
SN  - 2190-5738
ER  -